Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases

gan Al Jarroudi, Ouissam, Ulusakarya, Ayhan, Almohamad, Wathek, Afqir, Said, Morere, Jean-Francois
Cyhoeddwyd yn Cureus (2020)

Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas

gan Machover, David, Almohamad, Wathek, Castagné, Vincent, Desterke, Christophe, Gomez, Léa, Gaston-Mathé, Yann, Boucheix, Claude, Goldschmidt, Emma
Cyhoeddwyd yn Sci Rep (2021)

Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience

gan Al jarroudi, Ouissam, Chaabouni, Hamed, Ulusakarya, Ayhan, Almohamad, Wathek, Gumus, Yusuf, Goldschmidt, Emma, Afqir, Said, Morère, Jean‐francois
Cyhoeddwyd yn Clin Case Rep (2021)

Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma

gan Ulusakarya, Ayhan, Teyar, Nahla, Karaboué, Abdoulaye, Haydar, Mazen, Krimi, Sarra, Biondani, Pamela, Gumus, Yusuf, Chebib, Amale, Almohamad, Wathek, Morère, Jean-François
Cyhoeddwyd yn Medicine (Baltimore) (2019)

A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

gan Ulusakarya, Ayhan, Karaboué, Abdoulaye, Ciacio, Oriana, Pittau, Gabriella, Haydar, Mazen, Biondani, Pamela, Gumus, Yusuf, Chebib, Amale, Almohamad, Wathek, Innominato, Pasquale F.
Cyhoeddwyd yn BMC Cancer (2020)